merged_abortion-pill-ella.txt
<question_number>1</question_number>
<answer>N/A</answer>
<other>The study doesn't provide a comparison between ulipristal acetate plus misoprostol versus mifepristone plus misoprostol in controlled trial portions. It only states that the ulipristal acetate regimen had a 97% completion rate "that is similar to the regimen using mifepristone" but doesn't give specific numbers for a mifepristone control group.</other>

<question_number>2</question_number>
<answer>N/A</answer>
<other>The article doesn't mention Dr. Gomperts prescribing ulipristal acetate to patients. It only mentions that Dr. Gomperts is studying low doses of mifepristone as a weekly birth control pill in Europe, and that she considered the new ulipristal acetate study sufficient to prescribe it off-label with misoprostol.</other>

<question_number>3</question_number>
<answer>N/A</answer>
<other>The article doesn't mention any state attorney general filing litigation challenging Ella as emergency contraception following the publication of this study. It mentions that Students for Life of America would "absolutely" consider litigation over Ella, but no actual litigation by a state attorney general is mentioned.</other>

<question_number>4</question_number>
<answer>0%</answer>
<other>The article states "There were no serious complications, and the study concluded that using ulipristal acetate in the two-drug medication abortion regimen was safe."</other>

<question_number>5</question_number>
<answer>N/A</answer>
<other>The article states that Project 2025 said Ella should be removed from required insurance coverage under the ACA because it is "a potential abortifacient," but doesn't mention what should replace it.</other>

<question_number>6</question_number>
<answer>N/A</answer>
<other>The article states that Dr. Winikoff became increasingly interested in a possible role for ulipristal acetate after the Supreme Court overturned the national right to abortion in 2022, but doesn't specify how many days after the decision she began her research.</other>

<question_number>7</question_number>
<answer>N/A</answer>
<other>The article mentions that the FDA changed the language in 2022 to make it clear that Plan B acts only before fertilization, but doesn't explicitly state the primary reason for this change.</other>

<question_number>8</question_number>
<answer>N/A</answer>
<other>The article doesn't mention which pharmaceutical company funded the Mexico City portion of the study.</other>

<question_number>9</question_number>
<answer>24 to 48 hours</answer>
<other>The article states that in the standard two-drug regimen, "The second drug, misoprostol, is taken 24 to 48 hours later" after mifepristone. Since ulipristal acetate was substituted for mifepristone in the study, this would be the same interval.</other>

<question_number>10</question_number>
<answer>3</answer>
<other>The article states "The Supreme Court rejected that lawsuit last year, ruling that the initial plaintiffs lacked standing to sue, but the suit has since been revived with three states as plaintiffs."</other>

<question_number>11</question_number>
<answer>60 milligrams</answer>
<other>The article states "In the study, a 60 milligram dose of ulipristal acetate (double the 30 milligrams in Ella) was substituted for mifepristone and followed by misoprostol."</other>

<question_number>12</question_number>
<answer>N/A</answer>
<other>The article mentions that Students for Life of America would "absolutely" consider litigation over Ella, but doesn't mention any specific legal action they would take regarding the FDA's label change for Plan B One-Step.</other>

<question_number>13</question_number>
<answer>N/A</answer>
<other>While the article mentions the Texas attorney general suing a New York doctor for sending abortion pills into Texas, it doesn't provide enough information to determine what specific aspect of Ella would be central to a hypothetical lawsuit against Perrigo.</other>

<question_number>14</question_number>
<answer>N/A</answer>
<other>The study used a 60mg dose of ulipristal acetate (double the standard 30mg dose in Ella). There's no information about what percentage of pregnancies were terminated using only the standard 30mg dose.</other>

<question_number>15</question_number>
<answer>N/A</answer>
<other>The article mentions that misoprostol "has various medical uses" but doesn't specify what those other uses are in the context of the lawsuit against the FDA.</other>

<question_number>16</question_number>
<answer>N/A</answer>
<other>The article states that the Supreme Court rejected the initial lawsuit against the FDA, ruling that the plaintiffs lacked standing to sue, but it doesn't mention any action taken regarding the revived lawsuit with three states as plaintiffs.</other>

<question_number>17</question_number>
<answer>N/A</answer>
<other>The article mentions that Dr. Gomperts is "a Dutch physician and founder of telemedicine organizations that provide abortion pills globally" but doesn't name the specific organization.</other>

<question_number>18</question_number>
<answer>N/A</answer>
<other>The article doesn't specify the FDA label's primary mechanism of action for the drug used in the Washington State pilot program.</other>

<question_number>19</question_number>
<answer>N/A</answer>
<other>Dr. Beverly Winikoff is identified as the lead author of the study and president of Gynuity Health Projects, but the article doesn't state that she is researching low doses of mifepristone for birth control. That research is attributed to Dr. Rebecca Gomperts and others in Europe.</other>

<question_number>20</question_number>
<answer>progesterone</answer>
<other>The article states that both mifepristone and ulipristal acetate block the hormone progesterone. Specifically, it mentions that mifepristone "stops the development of a pregnancy by blocking the hormone progesterone" and that ulipristal acetate "also blocks the activity of progesterone."</other>